Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II TrialChunyan Lan, Xin Huang, JingXian Shen et al.|Journal of Clinical Oncology|2020Cited by 217
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancerWei Wei, Xiaohua Ban, Fan Yang et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 38
Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world studyShu‐Xian Lyu, Xueyan Cui, Ting Li et al.|老年心脏病学杂志：英文版|2023Cited by 8
The INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNAHui Luo, Rui‐Hua Xu, Wei Wei et al.|癌症：英文版|2025Cited by 5